Baxter International, Inc. (BAX)

NYSE: BAX · IEX Real-Time Price · USD
86.28 0.29 (0.34%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap43.20B
Revenue (ttm)12.45B
Net Income (ttm)1.21B
Shares Out500.69M
EPS (ttm)2.38
PE Ratio36.31
Forward PE20.37
Dividend$1.09 (1.26%)
Ex-Dividend DateDec 2, 2021
Volume2,348,357
Open86.65
Previous Close85.99
Day's Range85.51 - 86.82
52-Week Range73.12 - 88.91
Beta0.64
AnalystsBuy
Price Target97.80 (+13.4%)
Earnings DateFeb 17, 2022

About BAX

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical...

IndustryHealth Care Equipment & Supplies
Founded1931
CEOJose Almeida
Employees50,000
Stock ExchangeNYSE
Ticker SymbolBAX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is 97.80, which is an increase of 13.35% from the latest price.

Price Target
$97.80
(13.35% upside)
Analyst Consensus: Buy

News

New Strong Buy Stocks for January 18th

KBH, BAX, F, EGO, and AXS have been added to the Zacks Rank #1 (Strong Buy) List on January 18, 2022.

Other symbols:AXSEGOFKBH
5 days ago - Zacks Investment Research

Best Income Stocks to Buy for January 18th

BAX, F, and WBS made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 18, 2022

Other symbols:FWBS
5 days ago - Zacks Investment Research

Best Momentum Stocks to Buy for January 18th

BAX, F, and EGO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 18, 2022

Other symbols:EGOF
5 days ago - Zacks Investment Research

5 Low-Beta High-Yielding Stocks to Buy in a Capricious Market

We have narrowed our search to five large-cap low-beta stocks with a solid dividend yield. These are: PFE, BAX, IBKR, PSA and CUBE.

Other symbols:CUBEIBKRPFEPSA
5 days ago - Zacks Investment Research

New Strong Buy Stocks for January 17th

AXS, BAX, F, UNFI, and BRDG have been added to the Zacks Rank #1 (Strong Buy) List on January 17, 2022.

Other symbols:AXSBRDGFUNFI
6 days ago - Zacks Investment Research

Here's Why You Should Retain Baxter (BAX) Stock For Now

Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio.

2 weeks ago - Zacks Investment Research

Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2021 financial results on Thursday, February 17...

2 weeks ago - Business Wire

4 Stocks to Watch Out For as MedTech Rides on Buyout Frenzy

Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.

Other symbols:BDXQDELTMO
2 weeks ago - Zacks Investment Research

Alcoa Set to Join S&P MidCap 400

NEW YORK, Dec. 13, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400: Alcoa Corp. (NYSE:AA) will replace Hill-Rom Holdings Inc. (NYSE:HRC) in the S&P MidCa...

Other symbols:AA
1 month ago - PRNewsWire

Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader

DEERFIELD, Ill.--(BUSINESS WIRE)---- $BAX--Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for eac...

1 month ago - Business Wire

Baxter Presents Data at ASHP Meeting Indicating Machine Learning May Enhance Infusion Pump Programming Safety

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, announced new data from a retrospective study finding that machine lear...

1 month ago - Business Wire

4 MedTech Dividend Stocks in Focus on Amid Omicron Variant Panic

Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.

Other symbols:ABTCHEWST
1 month ago - Zacks Investment Research

Larry Robbins' Top 5 Trades of the 3rd Quarter

Glenview Capital Management, the firm founded by Larry Robbins (Trades, Portfolio), disclosed in November that its top five trades during the third quarter included a new holding in Willis Towers Watson...

Other symbols:UBER
1 month ago - GuruFocus

Baxter's (BAX) $100M Investment to Strengthen Global Presence

Baxter's (BAX) strategic investment to help expand the manufacturing footprint of BPS and ensure improvement in products.

2 months ago - Zacks Investment Research

Baxter Declares Quarterly Dividend

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $...

2 months ago - Business Wire

Baxter Named to Dow Jones Sustainability Indices in Recognition of Continued Commitment to Corporate Responsibility

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a leading global medical products company, today announced it was again named to the S&P's Dow Jones Sustainability Indices (DJSI...

2 months ago - Business Wire

Baxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufact...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter announced a $100M investment in its manufacturing facility in Halle/Westfalen, Germany that will add new capacity and capabilities.

2 months ago - Business Wire

Baxter Highlights New Data Indicating Sharesource Digital Health Platform for Home Dialysis May Improve Survival and ...

DEERFIELD, Ill.--(BUSINESS WIRE)-- #digitalhealth--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data showing kidney patients may experience a survival rate...

2 months ago - Business Wire

Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 4th Annual HealthCONx Conference on Thursday, December...

2 months ago - Business Wire

Baxter Shares Fall Despite Better-Than-Expected Q3 Earnings, FY21 EPS Outlook Boost

Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.23 billion, in line with the consensus, up 9% on a reported basis, 7% on a constant currency basis, and 6% on an operational basis. Adjusted ...

2 months ago - Benzinga

Baxter (BAX) Q3 Earnings and Revenues Surpass Estimates

Baxter's (BAX) third-quarter results reflect robust performance across all its business units.

2 months ago - Zacks Investment Research

Baxter International (BAX) Q3 Earnings and Revenues Beat Estimates

Baxter (BAX) delivered earnings and revenue surprises of 8.51% and 0.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Baxter Reports Third-Quarter 2021 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2021. “Baxter's essential products, div...

2 months ago - Business Wire

Baxter (BAX) to Report Q3 Earnings: What's in the Offing?

Baxter's (BAX) third-quarter results are likely to reflect growth in its Acute Therapies business.

3 months ago - Zacks Investment Research

Baxter International (BAX) Earnings Expected to Grow: Should You Buy?

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research